Latest news & insights
Dr Harriet Gray Stephens discusses the pros and cons of synthetic control arms in clinical trials
An article authored by Dr Harriet Gray Stephens MFPM, medical director at Boyds, has been published on the Clinical Leader website.
Chris Moore shares top tips for US biotechs setting up clinical studies in Europe
An article authored by Chris Moore, Clinical Project Manager at Boyds, has been featured by Clinical Leader.
Clinical pharmacology student completes internship with Boyds
Boyds recently welcomed Clinical Pharmacology BSc student Salma Muse to the team on a six-week internship.
The Maddi Foundation selected as Boyds’ Charity of the Year
We are proud to announce that we have chosen to support The Maddi Foundation as our Charity of the Year for 2024.
Harriet Edwards explores the current landscape for genome editing technologies
An article authored by Harriet Edwards, Associate Director of Regulatory Affairs at Boyds, has been published in Cell & Gene Therapy Insights. In the viewpoint
How To De-Risk Your IND Webinar
On March 20, 2024 at 9 am PST, Boyds will host a webinar designed to provide attendees with a plan of action that can help to de-risk your Investigational New Drug (IND) application and expedite the path to gain study clearance.
Boyds is now a proud member of MassBio
As part of our continued growth plans in the US, Boyds is delighted to join MassBio as a proud member.
Boyds shortlisted for BioNow Business Support Award
Boyds is delighted to have been named as a finalist in the Business Support category of the BioNow Awards 2023.
